HR Execs on the Move

Novocure

www.novocure.com

 
We are a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of our innovative therapy, Tumor Treating Fields. Our commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for the treatment of adult patients with malignant pleural mesothelioma. We have ongoing or completed clinical trials investigating Tumor Treating Fields in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer, liver cancer and gastric cancer. Headquartered in Jersey, Novocure has U.S. operations in Portsmouth, New Hampshire, Malvern, ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details
Pritesh Shah
 Chief Growth Officer Profile
Ed Palmgren
 Director, Revenue Operation - Government Reimbursement Profile
Bill Burke
 Global Head HR Profile
Hadas Artsi
 Associate Director, Human Resource Profile
Bill Burke
 Global Head Human Resource Profile

Similar Companies

OpSens

Fiber optic solutions for industrial applications: temperature, pressure, displacement, strain by Opsens Solutions. Contact us.

CAREstream America

Specializing in Respiratory, Patient Monitoring, Diagnostic, Anesthesia, Ventilation Biomedical and Plastic Surgery Products.

Bp Solvay Polyethylene

Bp Solvay Polyethylene is a Houston, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Produits Chimiques Delmar Inc

Produits Chimiques Delmar Inc is a Lasalle, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Clinical ink

Clinical ink is the global life science company that brings data, technology, and patient-centric research together. Our deep therapeutic-area expertise, coupled with Direct Data Capture, eCOA, eConsent, telehealth, neurocognitive testing, and digital biomarkers advancements, drive the industry standard for data precision and usher in a new generation of clinical trials. By harnessing digital data, we power sponsors, CROs, researchers, and patients to recenter decentralized trials and rewrite the clinical development experience.